New England Journal of Medicine Retracts Amgen Drug Trial Paper Amid Data Integrity Concerns
The New England Journal of Medicine (NEJM) has retracted a significant clinical trial paper that provided support for Amgen’s drug Tavneos. The retraction stems from concerns that patient outcome data within the study may have been altered and that some researchers involved in the trial were unblinded to treatment assignments. The paper, which played a […]